China’s Anbang Weighs Sale of Hexie Health Insurance: Sources


Anbang Insurance Group Co. is weighing a sale of its Hexie Health Insurance Co. unit as the troubled Chinese firm reviews its assets for possible divestment, according to people familiar with the matter.

The insurer is in discussions with financial advisers about a possible disposal of the unit after receiving interest, the people said, asking not to be identified because the matter is private. The health insurance firm could attract Chinese insurers as well as private equity funds, one of the people said.
A sale of Hexie Health would be the first major local asset sale for Beijing-based Anbang since the government seized temporary control of the insurer in February amid a campaign to curb financial system risk. After gaining renown for an aggressive global acquisition spree, the Chinese firm said earlier this year it was reviewing all of its overseas assets.

Hexie Health provides services ranging from disease management, medical care, disability care, health care and accident insurance in the world’s most populous country. Its net income jumped more than fivefold to 2.7 billion yuan ($405 million) in 2016 from the previous year, after revenue from premiums more than tripled, its latest annual report shows.

Considerations about a possible sale of Hexie Health are preliminary, no formal process is under way and discussions may not result in a deal, the people said. A spokesman for Anbang said the company doesn’t comment on speculation.
China, announced in May, has chosen banks at the beginning of this year to advise on the potential extermination of Anbang’s assets. Anbang is investigating a sale of Belgian insurance company Fidea who knows how to handle this month.

Legal warning !
The information, comments and suggestions there are not covered by investment advice. It is based on the author's personal opinions. These views may not fit your financial situation and risk and return preferences. For this reason, based solely on this information, investment decisions may not have the appropriate consequences for your expectation. Our Site is not responsible for any direct or indirect damages incurred by the investors as a result of the use of the information on the Site, deficiencies in the sources, damages incurred by profit, moral damages, or damage to third parties.